Directory of Stock Market Company
This site is a directory of Stock Market Company in USA and Canada. Each company page contains a description, stock quote, news and much more. You have also access to the best stock market game on the web.
Search into NYSE and TSX
by quote, company name or key word
AMPE - Ampio Pharmaceuticals Inc
Ampio Pharmaceuticals, Inc. (Ampio Pharmaceuticals), formerly Chay Enterprises, Inc., incorporated on March 29, 1996, develops proprietary drugs for metabolic disease, eye disease, kidney disease, inflammation and CNS disease. The product pipeline includes new uses for previously approved drugs and new molecular entities (NMEs).
Ampio Pharmaceuticals Inc News
Ampio Pharmaceuticals (NASDAQ:AMPE): Positioned For A Rebound
Market Playground - 19 hours ago
Market Playground - 19 hours ago
By VFC's Stock House After a five percent drop on Friday, shares of Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) started to rebound along with the broad markets on Monday, posting a three percent increase on the day.
Ampio Pharmaceuticals Is Positioned For A Rebound - Seeking Alpha
Weekly Stock Watch: FB, NBY, DNDN, AMPE, PFE, HGSI, ACTC, SGYP, IRWD, CTSO ...
The Mumbai Times - May 21, 2012
The Mumbai Times - May 21, 2012
The 20 analysts offering 12-month price forecasts for Dendreon Corp have a median target of 12.00, with a high estimate of 21.00 and a low estimate of 4.00.
Weekly Stock Watch: May 21-25
Seeking Alpha - May 21, 2012
Seeking Alpha - May 21, 2012
At the conclusion of each week,VFC's Stock House examines some news items, stocks and stories that made headlines during the previous trading week, but may also make headlines or influence trends during the upcoming week as well.
Why Ampio Pharmaceuticals Is A Strong Buy
Seeking Alpha - May 16, 2012
Seeking Alpha - May 16, 2012
I've been following the stock markets since 1969 when I worked as a securities analyst and trader for Charlie Munger and Warren Buffet, and my experience over the past 40 years has given me a pretty good sense of what stocks I should be buying and ...
Ampio Pharmaceuticals Schedules 2012 Update Webcast
MarketWatch (press release) - May 14, 2012
MarketWatch (press release) - May 14, 2012
GREENWOOD VILLAGE, Colo., May 14, 2012 /PRNewswire via COMTEX/ -- Ampio Pharmaceuticals, Inc. (NASDAQ:AMPE) , a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion(TM), Optina(TM) and Zertane(TM)), ...
Ampio (AMPE) Completes Pre-IND Meeting with FDA's CBER for Ampion
StreetInsider.com (subscription) - May 11, 2012
StreetInsider.com (subscription) - May 11, 2012
Ampio Pharmaceuticals, Inc. (Nasdaq: AMPE), has completed a pre-IND meeting with the Center for Biological Evaluation and Research (CBER) division of the FDA that took place on May 10th regarding Ampio's lead biologic, Ampion for the chronic treatment ...
Ampio Pharmaceuticals Ripe Target For Takeover By Big Pharma
Seeking Alpha - May 8, 2012
Seeking Alpha - May 8, 2012
Pharmaceutical drugs are big business, and Big Pharma is always on the hunt for new drugs to fill their pipeline of inventory expiring from patent protection.
Tolero and Agrees to Develop and Commercialize Novel BTK; Ampio Announces ...
BioMedReports (subscription) - Apr 30, 2012
BioMedReports (subscription) - Apr 30, 2012
By Staff and Wire Reports Below is a look at some of the headlines for companies that made news in the healthcare sector on April 30, 2012.
Stock Futures Edge Lower on Data. Stocks to Watch: AMPE, XOMA, CLNT, MNKD, LDK ...
Active Investor - Apr 30, 2012
Active Investor - Apr 30, 2012
With earnings season still going full force, investors get a chance to eye more domestic macro data ahead of Friday's all important unemployment gauge.
Ampio Pharmaceuticals announces extended analysis of Ampion(TM) In the Knee ...
MarketWatch (press release) - Apr 30, 2012
MarketWatch (press release) - Apr 30, 2012
GREENWOOD VILLAGE, Colo., April 30, 2012 /PRNewswire via COMTEX/ -- Ampio Pharmaceuticals, Inc. (UTD:AMPE) , a biopharmaceutical company conducting clinical trials on its three lead drugs (Ampion(TM), Optina(TM) and Zertane(TM)), licensing distribution ...
Ampio Pharmaceuticals announces extended analysis of Ampion™ In the Knee (AIK ... - Healthcare Global (press release) NYSE Media Coverage Selection of the best articles found in your favorit medias